ONCOTELIC CLOSES COVID-19 CLINICAL TRIAL EARLY.
15 juin 2021 09h00 HE
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, California, June 15, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic" or the “Company”), a leading developer of TGF-β therapeutics for oncology,...